186 related articles for article (PubMed ID: 36094384)
41. Opportunities to Improve HPV Vaccination Among Pediatric, Adolescent, and Young Adult Cancer Survivors by Engaging both Oncology and Primary Care Teams.
Butsch Kovacic M; Topalian A; Erickson M
Cancer Prev Res (Phila); 2023 Oct; 16(10):545-547. PubMed ID: 37779459
[TBL] [Abstract][Full Text] [Related]
42. Regional variation in human papillomavirus vaccination uptake and completion among adolescents 13-17 in the state of Texas.
Conrey R; Valencia V; Cioletti A; Williams-Brown MY
Vaccine; 2020 May; 38(25):4119-4124. PubMed ID: 32349907
[TBL] [Abstract][Full Text] [Related]
43. Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model.
Gomez JA; Lepetic A; Demarteau N
BMC Public Health; 2014 Nov; 14():1222. PubMed ID: 25424716
[TBL] [Abstract][Full Text] [Related]
44. Predictors of Human Papillomavirus Vaccination in a Large Clinical Population of Males Aged 11 to 26 years in Maryland, 2012-2013.
Clarke MA; Coutinho F; Phelan-Emrick DF; Wilbur M; Chou B; Joshu CE
Cancer Epidemiol Biomarkers Prev; 2016 Feb; 25(2):351-8. PubMed ID: 26698909
[TBL] [Abstract][Full Text] [Related]
45. Provider factors associated with disparities in human papillomavirus vaccination among low-income 9- to 17-year-old girls.
Vadaparampil ST; Staras SA; Malo TL; Eddleton KZ; Christie J; Rodriguez M; Giuliano AR; Shenkman EA
Cancer; 2013 Feb; 119(3):621-8. PubMed ID: 23341308
[TBL] [Abstract][Full Text] [Related]
46. "I don't Think He Needs the HPV Vaccine Cause Boys Can't Have Cervical Cancer": a Qualitative Study of Latina Mothers' (Mis) Understandings About Human Papillomavirus Transmission, Associated Cancers, and the Vaccine.
Lindsay AC; Delgado D; Valdez MJ; Restrepo E; Guzman YM
J Cancer Educ; 2022 Apr; 37(2):370-378. PubMed ID: 32654037
[TBL] [Abstract][Full Text] [Related]
47. Awareness of Human Papillomavirus (HPV) and HPV Vaccination amongst the General Population in Germany: Lack of Awareness and Need for Action.
Sharma SJ; Schartinger VH; Wuerdemann N; Langer C; Möllenhoff K; Collin L; Sutton L; Riedl D; Kreuter A; Lechner M; Wieland U; Klussmann JP
Oncol Res Treat; 2022; 45(10):561-567. PubMed ID: 35850111
[TBL] [Abstract][Full Text] [Related]
48. Medical and sociodemographic factors associated with human papillomavirus (HPV) vaccination adherence among female survivors of childhood cancer.
Klosky JL; Russell KM; Simmons JL; Foster RH; Peck K; Green DM; Hudson MM
Pediatr Blood Cancer; 2015 Sep; 62(9):1630-6. PubMed ID: 25900433
[TBL] [Abstract][Full Text] [Related]
49. Measuring Adolescent Human Papillomavirus Vaccine Coverage: A Match of Sexually Transmitted Disease Clinic and Immunization Registry Data.
Pathela P; Jamison K; Papadouka V; Kabir R; Markowitz LE; Dunne EF; Schillinger JA
J Adolesc Health; 2016 Dec; 59(6):710-715. PubMed ID: 27671357
[TBL] [Abstract][Full Text] [Related]
50. Subsequent malignant neoplasms in the Childhood Cancer Survivor Study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor.
Henderson TO; Fowler BW; Hamann HA; Nathan PC; Whitton J; Leisenring WM; Oeffinger KC; Neglia JP; Turcotte LM; Arnold MA; Conces MR; Howell RM; Robison LL; Armstrong GT; Alexander KA
Cancer; 2022 Jan; 128(2):373-382. PubMed ID: 34606625
[TBL] [Abstract][Full Text] [Related]
51. Human Papillomavirus Vaccination in South Africa: Programmatic Challenges and Opportunities for Integration With Other Adolescent Health Services?
Amponsah-Dacosta E; Blose N; Nkwinika VV; Chepkurui V
Front Public Health; 2022; 10():799984. PubMed ID: 35174123
[TBL] [Abstract][Full Text] [Related]
52. Human papillomavirus vaccinations at recommended ages: How a middle school-based educational and vaccination program increased uptake in the Rio Grande Valley.
Rodriguez AM; Do TQN; Chen L; Schmeler KM; Montealegre JR; Kuo YF
Hum Vaccin Immunother; 2022 Nov; 18(6):2133315. PubMed ID: 36252275
[TBL] [Abstract][Full Text] [Related]
53. Test Performance of Cervical Cytology Among Adults With vs Without Human Papillomavirus Vaccination.
Teoh D; Nam G; Aase DA; Russell R; Melton GB; Kulasingam S; Vogel RI
JAMA Netw Open; 2022 May; 5(5):e2214020. PubMed ID: 35612854
[TBL] [Abstract][Full Text] [Related]
54. Identifying Barriers to HPV Vaccination for Patients With Sickle Cell Disease and Childhood Cancer Survivors.
Rahim MQ; Jacob SA; Coven SL; Miller M; Meagher CG; Lozano G; Zimet G; Ott MA
J Pediatr Hematol Oncol; 2023 Nov; 45(8):e940-e947. PubMed ID: 37696002
[TBL] [Abstract][Full Text] [Related]
55. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007.
Jain N; Euler GL; Shefer A; Lu P; Yankey D; Markowitz L
Prev Med; 2009 May; 48(5):426-31. PubMed ID: 19100762
[TBL] [Abstract][Full Text] [Related]
56. Human Papillomavirus (HPV) Vaccination Initiation and Completion Among Adult Males in the United States.
Guo Y; Bowling J
J Am Board Fam Med; 2020; 33(4):592-599. PubMed ID: 32675270
[TBL] [Abstract][Full Text] [Related]
57. Facilitators and barriers of human papillomavirus vaccine uptake in young females 18-26 years old in Singapore: A qualitative study.
Lim ASE; Lim RBT
Vaccine; 2019 Sep; 37(41):6030-6038. PubMed ID: 31473002
[TBL] [Abstract][Full Text] [Related]
58. Knowledge and willingness of parents towards child girl HPV vaccination in Debre Tabor Town, Ethiopia: a community-based cross-sectional study.
Mihretie GN; Liyeh TM; Ayele AD; Belay HG; Yimer TS; Miskr AD
Reprod Health; 2022 Jun; 19(1):136. PubMed ID: 35689288
[TBL] [Abstract][Full Text] [Related]
59. Socioeconomic disadvantage and human papillomavirus (HPV) vaccination uptake.
Kurani S; MacLaughlin KL; Jacobson RM; St Sauver JL; Jenkins GD; Fan C; Jacobson DJ; Inselman J; Zhu X; Griffin JM; Finney Rutten LJ
Vaccine; 2022 Jan; 40(3):471-476. PubMed ID: 34916103
[TBL] [Abstract][Full Text] [Related]
60. Knowledge, Attitudes and Practices Towards Human Papillomavirus Vaccination Among Medical Doctors at a Tertiary Hospital: A Cross Sectional Study.
Lubeya MK; Zekire Nyirenda JC; Chanda Kabwe J; Mukosha M
Cancer Control; 2022; 29():10732748221132646. PubMed ID: 36214063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
